Universe Pharmaceuticals INC

Informe acción NasdaqCM:UPC

Capitalización de mercado: US$2.9m

Universe Pharmaceuticals Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Gang Lai

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO8.8%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

CEO

Gang Lai (56 yo)

no data

Permanencia

Mr. Gang Lai serves as the Chief Executive Officer and chairman of the board at Universe Pharmaceuticals INC. Mr. Lai has served as the chief executive officer of Jiangxi Universe since 2004 and founded Un...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Gang Lai
CEO & Chairmanno datasin datos8.8%
$ 256.5k
Lin Yang
CFO & Directorno datasin datossin datos
Jiawen Pang
Independent Director3.7yrssin datossin datos
Yongping Yu
Independent Director1.5yrssin datossin datos
Ding Zheng
Independent Director3.7yrssin datossin datos

3.7yrs

Permanencia media

55yo

Promedio de edad

Junta con experiencia: La junta directiva de UPC se considera experimentada (3.7 años de antigüedad promedio).